SynchroMed II Post-Approval Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

84 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-11-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This FDA Condition of Approval study will include up to 100 subjects at up to 13 US centers. Subjects are selected from those evaluated and planning to receive a SynchroMed II drug infusion system for treatment of severe spasticity or chronic pain. Subjects must return for refill visits at 1, 6, and 12 months. In addition, subjects return for any other medically necessary refills. Information is collected on all refills and adverse events.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Medtronic PSR TDD PMCF

NCT04714385

Chronic Pain Spasticity, Muscle

COMPLETED

Users Study Of The Caverject Delivery System

NCT01747928

Healthy

COMPLETED EARLY_PHASE1

Reciprocating Medical Devices - a Study of a New Safety Device

NCT00651625

Osteoarthritis Rheumatoid Arthritis Trauma +2 more

COMPLETED NA

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

NCT05743842

Liver Cancer

ACTIVE_NOT_RECRUITING NA

Alinity s Anti-HCV II - Clinical Evaluation Protocol

NCT04862065

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe Spasticity Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Refills (SynchroMed® II Programmable Drug Infusion Pump)

Refill information at 1, 6, and 12 months post-implant, as well as any additional refills required from implant through end of study. Amount removed from the pump (taken from syringe), Amount placed in the pump (from syringe),Pump predicted amount remaining in the pump.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have chronic intractable severe spasticity or chronic pain requiring intrathecal delivery of medication
* Have undergone a pre-implant assessment and determined to be an appropriate candidate for implantation of an infusion system
* Be geographically stable and willing to return to the study center for follow-up visits
* Subject, or subject's legal representative, has signed informed consent form prior to any study-related procedures
* Age is at least 18 years of age at time of enrollment

Exclusion Criteria

* Have a condition in which the pump cannot be implanted 2.5 cm or less from the surface of the skin
* Have an ongoing infection prior to implant
* Have insufficient body mass to accept the pump bulk and weight
* Are unable or unwilling to adhere to the study protocol
* Have an estimated life expectancy of less than twelve months

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No